Verrica Pharmaceuticals Inc. - 10-Q Filing
Verrica Pharmaceuticals reports Q3 2026 financial results including new secured debt obligations and derivative valuations.
Tickers: $VRCA
Verrica Pharmaceuticals reports Q3 2026 financial results including new secured debt obligations and derivative valuations.
Tickers: $VRCA